Genetic Variants as Targets for Immunotherapy of Hematological Tumors

22k
Total downloads
82k
Total views and downloads

Download PDF Download EPUB

Articles

ORIGINAL RESEARCH

Published on 20 Aug 2020

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

Peter van Balen
Inge Jedema
Marleen M. van Loenen
Renate de Boer
H. M. van Egmond
Renate S. Hagedoorn
Conny Hoogstaten
Sabrina A. J. Veld
Lois Hageman
5 more
Mirjam H. M. Heemskerk

doi 10.3389/fimmu.2020.01804

3,772 views
27 citations

MINI REVIEW

Published on 24 Jun 2020

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction

Tuna Mutis
Anastasia Xagara
Robbert M. Spaapen

doi 10.3389/fimmu.2020.01162

2,328 views
8 citations

MINI REVIEW

Published on 10 Jun 2020

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect

Eun Young Choi
Kyungho Choi
Giri Nam
Woojin Kim
Minho Chung

doi 10.3389/fimmu.2020.01163

2,989 views
3 citations

OPINION

Published on 28 Apr 2020

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions

Elizabeth Krieger
Amir Ahmed Toor

doi 10.3389/fimmu.2020.00777

1,741 views
2 citations

ORIGINAL RESEARCH

Published on 17 Apr 2020

Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens

Kyra J. Fuchs
M. Willy Honders
Edith D. van der Meijden
Alwin E. Adriaans
Dyantha I. van der Lee
Margot J. Pont
Ramin Monajemi
Szymon M. Kielbasa
Peter A. C. ’t Hoen
2 more
Marieke Griffioen

doi 10.3389/fimmu.2020.00659

3,193 views
9 citations

ORIGINAL RESEARCH

Published on 11 Mar 2020

Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase

Anita N. Kremer
Judith Bausenwein
Ellie Lurvink
Andreas E. Kremer
Caroline E. Rutten
Cornelis A. M. van Bergen
Sascha Kretschmann
Edith van der Meijden
Maria W. Honders
4 more
Marieke Griffioen

doi 10.3389/fimmu.2020.00381

2,669 views
8 citations

MINI REVIEW

Published on 28 Feb 2020

TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens

Yoshiki Akatsuka

doi 10.3389/fimmu.2020.00257

13,876 views
36 citations

REVIEW

Published on 21 Feb 2020

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies

Valérie Janelle
Caroline Rulleau
Simon Del Testa
Cédric Carli
Jean-Sébastien Delisle

doi 10.3389/fimmu.2020.00276

9,054 views
41 citations

REVIEW

Published on 14 Feb 2020

Neoantigens in Hematologic Malignancies

Melinda A. Biernacki
Marie Bleakley

doi 10.3389/fimmu.2020.00121

9,685 views
32 citations

ORIGINAL RESEARCH

Published on 10 Jan 2020

Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis

Paul G. Kemps
Timo C. Zondag
Eline C. Steenwijk
Quirine Andriessen
Jelske Borst
Sandra Vloemans
Dave L. Roelen
Lenard M. Voortman
Robert M. Verdijk
17 more
Astrid G. S. van Halteren

doi 10.3389/fimmu.2019.03045

5,437 views
5 citations

PERSPECTIVE

Published on 20 Dec 2019

The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy

Marie-Pierre Hardy
Krystel Vincent
Claude Perreault

doi 10.3389/fimmu.2019.02934

6,504 views
6 citations

MINI REVIEW

Published on 20 Dec 2019

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?

Malte Roerden
Annika Nelde
Juliane S. Walz

doi 10.3389/fimmu.2019.03004

9,557 views
21 citations

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

82kTopic views
58kArticle views
22kArticle downloads

View impact

Submit your idea

Articles

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions

Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens

Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase

TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies

Neoantigens in Hematologic Malignancies

Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis

The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?

Frontiers in Immunology

Participating Journals

Impact